SACLAC
SACLAC is a small molecule inhibitor that targets cysteine asparaginase activation, exhibiting antitumor activity in acute myeloid leukemia (AML) research. It reduces cell viability and proliferation while inducing apoptosis, as demonstrated in in vitro studies of cancer cell lines.
Product Specifications
CAS Number
2248703-42-4
Product Name Alternative
Caspase, Apoptosis, SACLAC
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
96.24% (May vary between batches)
Smiles
[C@H] ([C@@H] (CCCCCCCCCCCCCCC) O) (NC (CCl) =O) CO
Molecular Formula
C20H40ClNO3
Molecular Weight
377.99
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62438R-BF350-01 20 µL
RanBP3 Recombinant Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details 
bsm-62438R-BF350-02 100 µL
RanBP3 Recombinant Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details 
GR133012 50 µg
Genorise® Biotinylated Human CXCL10 polyclonal antibody
Sign In for Pricing
View Details VAng-Wyb4014-1mg 1 mg
Recombinant Aspergillus Oryzae SFH5 Protein (aa 1-455) [His]
Sign In for Pricing
View Details